Cargando…

A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis

Phytocannabinoids that do not produce psychotropic effects are considered of special interest as novel therapeutic agents in CNS diseases. A cannabigerol quinone, the compound VCE-003, has been shown to alleviate symptoms in a viral model of multiple sclerosis (MS). Hence, we studied T cells and mac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrillo-Salinas, Francisco J., Navarrete, Carmen, Mecha, Miriam, Feliú, Ana, Collado, Juan A., Cantarero, Irene, Bellido, María L., Muñoz, Eduardo, Guaza, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984273/ https://www.ncbi.nlm.nih.gov/pubmed/24727978 http://dx.doi.org/10.1371/journal.pone.0094733

Ejemplares similares

Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus
por: Mecha, Miriam, et al.
Publicado: (2013)

Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
por: Mecha, Miriam, et al.
Publicado: (2020)

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy
por: Navarrete, Carmen, et al.
Publicado: (2018)

Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
por: Hernangómez, Miriam, et al.
Publicado: (2014)

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis
por: Mestre, Leyre, et al.
Publicado: (2019)

Involvement of Wnt7a in the role of M2c microglia in neural stem cell oligodendrogenesis
por: Mecha, Miriam, et al.
Publicado: (2020)

How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process
por: Mestre, Leyre, et al.
Publicado: (2020)

VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease
por: Díaz-Alonso, Javier, et al.
Publicado: (2016)

Gut dysbiosis and neuroimmune responses to brain infection with Theiler’s murine encephalomyelitis virus
por: Carrillo-Salinas, F. J., et al.
Publicado: (2017)

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis
por: Calvo-Barreiro, Laura, et al.
Publicado: (2020)

Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis
por: Calvo-Barreiro, Laura, et al.
Publicado: (2021)

Aging and neuroinflammation: Changes in immune cell responses, axon integrity, and motor function in a viral model of progressive multiple sclerosis
por: Mestre, Leyre, et al.
Publicado: (2021)

Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis
por: Laso-García, Fernando, et al.
Publicado: (2018)

Biosynthesis of cannabigerol and cannabigerolic acid: the gateways to further cannabinoid production
por: Kearsey, Lewis J, et al.
Publicado: (2023)

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor
por: García, Concepción, et al.
Publicado: (2018)

Testicular steroidogenesis is suppressed during experimental autoimmune encephalomyelitis in rats
por: Milosevic, Ana, et al.
Publicado: (2021)

Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis
por: Zhang, Zhihui, et al.
Publicado: (2022)

The Origin and Biomedical Relevance of Cannabigerol
por: Jastrząb, Anna, et al.
Publicado: (2022)

Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus
por: Xie, Changping, et al.
Publicado: (2006)

Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
por: Chiuso-Minicucci, Fernanda, et al.
Publicado: (2015)

Tim-3 Relieves Experimental Autoimmune Encephalomyelitis by Suppressing MHC-II
por: Tang, Lili, et al.
Publicado: (2022)

Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis
por: Cavalcanti, Fernando, et al.
Publicado: (2022)

Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration
por: Aguareles, José, et al.
Publicado: (2019)

Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress
por: Mecha, M, et al.
Publicado: (2012)

Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives
por: Calapai, Fabrizio, et al.
Publicado: (2022)

Hsp70 Regulates Immune Response in Experimental Autoimmune Encephalomyelitis
por: Mansilla, M. José, et al.
Publicado: (2014)

Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013)

Environmental Influences in Experimental Autoimmune Encephalomyelitis
por: Constantinescu, Cris S
Publicado: (2005)

P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis
por: Sharp, Anthony J, et al.
Publicado: (2008)

Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
Publicado: (2015)

Suppression of experimental autoimmune encephalomyelitis by ultraviolet light is not mediated by isomerization of urocanic acid
por: Irving, Amy A., et al.
Publicado: (2017)

Therapeutic Effect of IL-21 Blockage by Gene Therapy in Experimental Autoimmune Encephalomyelitis
por: Edo, Ángel, et al.
Publicado: (2022)

Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
por: Shin, Taekyun, et al.
Publicado: (2012)

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Girolamo, Francesco, et al.
Publicado: (2014)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
por: Basler, Michael, et al.
Publicado: (2014)

Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis
por: Lutz, Sarah E., et al.
Publicado: (2013)

The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis
por: Birkner, Katharina, et al.
Publicado: (2017)

Amelioration of experimental autoimmune encephalomyelitis by Ishige okamurae
por: Ahn, Meejung, et al.
Publicado: (2018)

Oryeongsan (Goreisan) Ameliorates Experimental Autoimmune Encephalomyelitis
por: Inada, Rino, et al.
Publicado: (2019)

Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis
por: Saligrama, Naresha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hrhpm0anv6gvcjmenjp1oks50r